TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients Differences between euthyrold, untreated hypothyroid, and euthyrold on L-T4 therapy patients

被引:127
作者
Cappelli, Carlo [1 ]
Rotondi, Mario [2 ]
Pirola, Ilenia [1 ]
Agosti, Barbara [3 ]
Gandossi, Elena [1 ]
Valentini, Umberto [3 ]
De Martino, Elvira [1 ]
Cimino, Antonio [3 ]
Chiovato, Luca [2 ]
Agabiti-Rosei, Enrico [1 ]
Castellano, Maurizio [1 ]
机构
[1] Univ Brescia, Internal Med & Endocrinol Unit, Dept Med & Surg Sci, Brescia, Italy
[2] Univ Pavia, Unit Internal Med & Endocrinol, Fdn Salvatore Maugeri,Lab Endocrine Disruptors, Ist Ricovero & Cura Carattere Sci,Ist Super Preve, I-27100 Pavia, Italy
[3] Spedali Civil Brescia, Diabet Unit, I-25125 Brescia, Italy
关键词
MELLITUS; WOMEN;
D O I
10.2337/dc09-0273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To assess the interplay between metformin treatment and thyroid function in type 2 diabetic patients. RESEARCH DESIGN AND METHODS - The acute and long-term effects Of metformin on thyroid axis hormones were assessed in diabetic patients with primary hypothyroidism who were either untreated or treated With levothyroxine (L-T4), as well as in diabetic patients With normal thyroid function. RESULTS- No acute changes were found in 11 patients with treated hypothyroidism. After I year of metformin administration, a significant thyrotropin (TSH) decrease (P < 0.001) was observed in diabetic subjects with hypothyroidism who were either treated (n 29; from 2.37 +/- 1.17 to 1.41 +/- 1.21 mIU/l) or untreated (n = 18; 4.5 +/- 0.37 vs. 2.93 +/- 1.48) with L-T4, but not in 54 euthyroid Subjects. No significant change in free T4 (FT4) was observed in any group. CONCLUSIONS - Metformin administration influences TSH without change of FT4 in patients with type 2 diabetes and concomitant hypothyroidism. The need for reevaluation of thyroid function in these patients within 6-12 months after starting metformin is indicated.
引用
收藏
页码:1589 / 1590
页数:2
相关论文
共 9 条
[1]   Approaches to treatment of type 2 diabetes [J].
Bloomgarden, Zachary T. .
DIABETES CARE, 2008, 31 (08) :1697-1703
[2]   Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study [J].
Chubb, SAP ;
Davis, WA ;
Inman, Z ;
Davis, TME .
CLINICAL ENDOCRINOLOGY, 2005, 62 (04) :480-486
[3]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[4]   Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy [J].
Isidro, M. Luisa ;
Penin, Manuel A. ;
Nemina, Rosa ;
Cordido, Fernando .
ENDOCRINE, 2007, 32 (01) :79-82
[5]   Drug interactions of clinical importance with antihyperglycaemic agents - An update [J].
Scheen, AJ .
DRUG SAFETY, 2005, 28 (07) :601-631
[6]   Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes [J].
Schwartz, S ;
Fonseca, V ;
Berner, B ;
Cramer, M ;
Chiang, YK ;
Lewin, A .
DIABETES CARE, 2006, 29 (04) :759-764
[7]  
STOCKER DJ, 87 ANN M END SOC 200
[8]   Thyrotropin suppression by metformin [J].
Vigersky, RA ;
Filmore-Nassar, A ;
Glass, AR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :225-227
[9]   Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus:: a randomized, placebo-controlled trial [J].
Wulffelé, MG ;
Kooy, A ;
Lehert, P ;
Bets, D ;
Ogterop, JC ;
Van der Burg, BB ;
Donker, AJM ;
Stehouwer, CDA .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (05) :455-463